IL-1α Blockade May Fight Metastatic Cancer

Targeting key anti-inflammatory molecules may be a novel treatment route for patients with metastatic disease

ESMO members: your membership includes full access to OncologyPRO Daily News, created exclusively for you by medwireNews. Sign in now to access this page.